HIV, Vaginal Sex and PrEP Initiation: What Should You Tell Your Patients or Clients? (thebody.com)

This year, pre-exposure prophylaxis (PrEP) advocates noted a stunning disconnect between key organizations that issue guidelines on the use of tenofovir/emtricitabine (TDF/FTC, Truvada) for HIV prevention: The United States Centers for Disease Control and Prevention (CDC) continues to say that people need 20 days of daily TDF/FTC before they can consider themselves protected from vaginal … Continue reading HIV, Vaginal Sex and PrEP Initiation: What Should You Tell Your Patients or Clients? (thebody.com)